Nippon Shinyaku Co., Ltd. (NPNKF)
- Previous Close
25.58 - Open
26.08 - Bid 22.94 x 30000
- Ask 26.89 x 40000
- Day's Range
26.08 - 26.08 - 52 Week Range
23.58 - 55.55 - Volume
90 - Avg. Volume
184 - Market Cap (intraday)
1.724B - Beta (5Y Monthly) -0.28
- PE Ratio (TTM)
7.64 - EPS (TTM)
3.35 - Earnings Date Aug 5, 2025 - Aug 11, 2025
- Forward Dividend & Yield 0.87 (3.39%)
- Ex-Dividend Date Sep 29, 2025
- 1y Target Est
--
Nippon Shinyaku Co., Ltd. manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally. The company operates through Pharmaceuticals and Functional Food Business segments. Its Pharmaceuticals Business segment offers drugs in the fields of urology, hematology, intractable and rare diseases, gynecology, and other diseases. The company's Functional Food Business segments provides health food ingredients, preservatives, protein preparations, and sports and supplements. The company in the Strategic Partnership with Nippon Shinyaku will develop and commercialize for Mucopolysaccharidosis. Nippon Shinyaku Co., Ltd. was founded in 1911 and is headquartered in Kyoto, Japan.
www.nippon-shinyaku.co.jp--
Full Time Employees
March 31
Fiscal Year Ends
Sector
Recent News: NPNKF
View morePerformance Overview: NPNKF
Trailing total returns as of 6/13/2025, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare to: NPNKF
Select to analyse similar companies using key performance metrics; select up to four stocks.
Statistics: NPNKF
View moreValuation Measures
Market Cap
1.72B
Enterprise Value
1.33B
Trailing P/E
7.63
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.55
Price/Book (mrq)
1.01
Enterprise Value/Revenue
1.19
Enterprise Value/EBITDA
4.49
Financial Highlights
Profitability and Income Statement
Profit Margin
20.32%
Return on Assets (ttm)
8.10%
Return on Equity (ttm)
13.92%
Revenue (ttm)
160.23B
Net Income Avi to Common (ttm)
32.56B
Diluted EPS (ttm)
3.35
Balance Sheet and Cash Flow
Total Cash (mrq)
55.24B
Total Debt/Equity (mrq)
1.10%
Levered Free Cash Flow (ttm)
-1.67B